Vimta Labs Ltd (BSE: 524394) is a Hyderabad, Telangana-based company in the Life Sciences Tools and Services industry. With a market capitalisation of ₹2,338 Cr, it ranks #1,162 by market cap among the 6,137 Indian listed companies on FinBizNet, and #3 of 10 in Life Sciences Tools and Services. At ₹468.00 (as of 25 Oct 2026), the share price is 36.3% below its 52-week high of ₹735.00 and 24.5% above its 52-week low of ₹376.05. The share price is down 32.5% over one year and down 18.0% over three months.
| Current Price | ₹468.00 |
|---|---|
| Market Cap | ₹2,338 Cr |
| BSE Code | 524394 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 29.3 |
| Return on Equity | 18.55% |
| Return on Assets | 12.19% |
| 52-Week Range | ₹376.05 – ₹735.00 |
| 1-Year Price Change | -32.5% |
| 3-Month Price Change | -18.0% |
| Beta (1Y) | 0.72 |
| Dividend Yield | 0.40% |
| Headquarters | Hyderabad, Telangana |
| Website | vimta.com |
| Revenue | ₹109 Cr |
|---|---|
| Net Profit | ₹21 Cr |
| Net Margin | 19.3% |
| EPS (Basic) | ₹4.71 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides
1. Contract Research and Testing Services-This segment provides contract research and testing services.
1. Contract Research and Testing Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Indegene Ltd | ₹14,413 Cr | 35.2 | 13.94% | ₹1,063 Cr | +5.9% |
| Suven Life Sciences Ltd. | ₹8,583 Cr | -24 | -78.80% | ₹4 Cr | +30.6% |
| Vimta Labs Ltd | ₹2,338 Cr | 29.3 | 18.55% | ₹109 Cr | -32.5% |
| Tarsons Products Limited | ₹1,762 Cr | 117.2 | 2.26% | ₹110 Cr | +3.3% |
| Bilcare Ltd. | ₹224 Cr | 122.4 | -5.21% | — | — |
| Brooks Laboratories Ltd. | ₹199 Cr | 8.1 | 22.28% | ₹23 Cr | -53.0% |
| Jeevan Scientific Technology Ltd | ₹178 Cr | 130.4 | 1.68% | — | +34.0% |
| Vivo Bio Tech Ltd. | ₹31 Cr | -16.6 | -2.00% | ₹14 Cr | -55.7% |
| Dr. Habeebbullal Life Sciences Ltd | ₹28 Cr | -2.8 | -68.79% | — | -32.7% |
Listed by market capitalisation. Ratios are shown for context only.
Vimta Labs Ltd is trading at ₹468.00, with a market capitalisation of ₹2,338 Cr.
Vimta Labs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Vimta Labs Ltd has a P/E of 29.3 and a return on equity of 18.55%.
Vimta Labs Ltd is listed on the BSE under the scrip code 524394.
Vimta Labs Ltd's share price is down 32.5% over one year and down 18.0% over three months. Its 52-week range is ₹376.05 to ₹735.00.
In Q1 FY27, Vimta Labs Ltd reported revenue of ₹109 Cr and net profit of ₹21 Cr, with basic EPS of ₹4.71 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.